Massachusetts · 194th Legislature (2025-2026) · Bill
H 2203: An Act establishing a pilot program for access to regulated psilocybin
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2203 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act establishing a pilot program for access to regulated psilocybin. Primary sponsor: Marjorie Decker (Democratic). It lists 1 additional sponsor. Most recent recorded action (July 22, 2026): Committee recommended bill ought to pass and referred to the committee on House Ways and Means.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 2203) of Marjorie C. Decker for legislation to authorize the Department of Public Health to establish a pilot program for psilocybin services for adults with post-traumatic stress disorder and other specified conditions. Mental Health, Substance Use and Recovery.
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Marjorie Decker | Primary sponsor | Democratic | House | 25th Middlesex |
| Estela Reyes | Co-sponsor | Democratic | House | 4th Essex |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- Reporting date extended to Thursday, December 31, 2026
- Reported favorably by committee and referred to the committee on Health Care Financing
- Reporting date extended to Wednesday, March 18, 2026
- Hearing scheduled for 11/10/2025 from 01:00 PM-05:00 PM in A-2
- Senate concurred
- Referred to the committee on Mental Health, Substance Use and Recovery